Evidence map›Paper›PMID 41381372›Full record

ArticleBiomacromolecules2026

Biodegradable Polyglycerols Combining Antioxidant Activity and Sulfation-Induced Complement Inhibition.

Hanna Koeppe, Daniel Horn, Jens Dernedde, Rainer Haag

Abstract read
In one paragraph

Article in Biomacromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanna KoeppeInstitute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Daniel HornInstitute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0002-8895-556X
Jens DerneddeInstitute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.ORCID 0000-0001-5319-7677
Rainer HaagInstitute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0003-3840-162X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyglycerol platforms are promising for polymer therapeutics due to their multifunctionality and biocompatibility. Our aim was to introduce biodegradability as well as antioxidant properties to the polyglycerol backbone using cyclic comonomers with thioether and ester functionalities. Anionic ring-opening copolymerization of glycidol and either 1,4-oxathiepan-7-one or thiodiglycolic anhydride yielded the hyperbranched structures: GOTO or GTA, respectively. Characterization confirmed molecular weights of 10 kDa and the successful incorporation of 10 mol % comonomer while maintaining water solubility. Sulfated derivatives, GOTO-S and GTA-S, were obtained with a high degree of sulfation. All copolymers showed good cytocompatibility as well as degradability under physiological conditions. Significant antioxidant activity attributed to the thioether groups of the copolymers was demonstrated via the ABTS radical scavenging assay. GTA emerged as the strongest radical scavenger among the polymers tested, likewise, GTA-S outperformed GOTO-S. Notably, the sulfated derivatives effectively inhibit complement activation with potencies comparable to dPGS and heparin, demonstrating their potential for applications in oxidative stress-related inflammation.

Indexed as

AntioxidantsComplement Inactivating AgentsGlycerolPolymersSulfatesAnimalsBiocompatible MaterialsComplement ActivationHumansMiceAntioxidantsBiocompatible MaterialsComplement Inactivating AgentsGlycerolpolyglycerolPolymersSulfates

Identifiers

PMID41381372
PMCPMC12801186

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.